Insilico Medicine Company
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Investors
%20.jpg)
%20.jpg)
Connections from
%20.png)
Funding Status:
Late Stage Venture
Industry:
Anti-aging Therapies
Estimated Revenue:
$1M to $10M
Number Of Exists:
11-50
Headquarters:
Hong Kong, Hong Kong Island, Hong Kong
Total Funding:
401300000
Last Funding Date:
2022-08-10
Last Funding Type:
Series D
Employee Number:
101-250
Investors Number:
32
Founded Date:
2014-01-01